Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
86 Cards in this Set
- Front
- Back
what kind of disease is gout?
|
hyperuricemia, acute athritis, accumulation of urate crystals
|
|
medication for gout?
|
allopurinol (Zyloprim)
|
|
what is Lesch-Nyhan syndrome?
|
hyperuricemia, neurologic problems, motor disability, failure to hold up head, SELF INJUROUS behavior striking feature
|
|
what is Lesch-Nyhan syndrome resembled to?
|
cerebral palsy
|
|
metabolic fcns of purine and pyrimidne nucleotdies/
|
atp energy, dna and rna components, second messengers(cAMP), coenzyme(NAD, CoA), allosteric effectors (ATP, AMP)
|
|
what are processes requiring rapid DNA and RNA synthesis?
|
embryogenesis, hemaptopoiesis-(RBC, lymphocytes), rapidly regenerating tissues, tumor cell growth
|
|
what is a nucleoside?
|
N base and sugar
|
|
nucleotide
|
N base and sugar and phosphate
|
|
purine base-nucleoside-nucleotide of adenine
|
adenine-adenosine--AMP
|
|
purine base-nucleoside-nucleotide of guanine
|
guanine→guanosine→GMP
|
|
purine base - nucleoside-nucleotide of hypoxanthine
|
hypoxanthine→ inosine→ IMP
|
|
purine base-nucleoside-nucleotide of xanthine
|
xanthine → xanthosine → XMP
|
|
purine bases?
|
uric acid, adenine, guanine, hypoxanthine, xanthine
|
|
typesof pyrimidine?
|
uracil, thymine, cytosine, orotic acid
|
|
pyrimidine bases - nucleoside - nucleotide of uracil
|
uracil→uridine→UMP
|
|
pyrimidine bases - nucleoside - nucleotide of thymine
|
embryogenesis, hemaptopoiesis-(RBC, lymphocytes), rapidly regenerating tissues, tumor cell growth
|
|
pyrimidine bases - nucleoside - nucleotide of cytosine
|
cytosine → cytidine → CMP
|
|
pyrimidine bases - nucleoside - nucleotide of orotic acid
|
orotic acid → orotidine → OMP
|
|
how does body get ribonucleotides?
|
de novo synthesis, purines, nucleoside
|
|
enzymes in nucleotide metabolism
|
ribonucleotide reductase, kinase, polymerase, nuclease, nucleotidase, phosphorylase
|
|
ex of ribonucleotide reductase
|
NDPs→ dNDP
|
|
ex of kinase
|
NMP+ ATP→ NDP+ ATP→ NTP
|
|
ex of polymerase
|
NTP→RNA, dNTP→DNA
|
|
ex of nuclease
|
RNA→ribonucleotide, DNA→deoxyribonucleotides
|
|
ex of nucleotidase
|
NTP+H20→ NDP+H20→ NMP+Pi
|
|
ex of phosphorylase
|
nucleosides→purine base + ribose 1 P
|
|
structure of purine ring--number C, N
|
N 1,3,7,9 C 2,4,5,6,7
|
|
where do C2,8 get C from in purines?
|
tetrahydrofolate-C2,8
|
|
where does C6 get C from in purines?
|
CO2
|
|
where do C4, C5, N7 get atoms from in purines?
|
glycine
|
|
where do N3,9 get N from in purines?
|
glutamine
|
|
where does N1 come from in purines?
|
aspartic acid
|
|
what is the first regulated step of de novo synthesis of purine nucleotides?
|
formation of PRPP from ribose 5 phosphate (scaffold) upon which purine ring is built
|
|
what is the enzyme of the first regualted step of de novo synthesis of purine nucleotides?
|
PRPP synthetase
|
|
what inhibits the first regulated step of de novo synthesis of purine nucleotides?
|
ADP, GDP, other nucleotdies
|
|
what is fate of PRPP?
|
purine nucleotides, pyrimidine nucleotides, NAD, NADP
|
|
what is the committed step of de novo synthesis of purine nucleotides?
|
formation of 5 Phosphoribosylamine (PRA)-first nucleotide from PRPP with glutamine
|
|
what is the enzyme of the committed step of de novo synthesis of purine nucleotides?
|
PRA synthase or PRPP amidotransferase
|
|
what inhibits the committed step of de novo synthesis of purine nucleotides?
|
AMP, GMP, IMP
|
|
what activates the committed step of de novo synthesis of purine nucleotides?
|
PRPP synthetase
|
|
what happens when AMP plus IMP or GMP is added into committed step?
|
total blockage of PRA synthase activity
|
|
fate of PRA?
|
IMP
|
|
significance of IMP?
|
branch point for forming both AMP and GMP
|
|
how is GMP formed from IMP?
|
IMP→ XMP + glutamine + ATP → glutamine
|
|
enzymes involved in GMP formation from IMP?
|
IMP dehydrogenase, GMP synthase
|
|
how is AMP formed from IMP?
|
IMP+ asparate + GTP→ adenylosuccinate→ AMP + fumarate
|
|
enzymes involved in AMP formation from IMP?
|
adenylosuccinate synthetase, adenylosuccinase
|
|
what inhibitsIMP from forming into XMP→GMP→GDP→GTP
|
GMP, later ATP
|
|
what inhibits IMP from forming into adenylosuccinate → AMP→ADP→ATP?
|
AMP, GTP
|
|
how is hyperuricemia caused?
|
superactive PRPP synthetase, excess PRPP broken down to uric acid
|
|
how is adenine salvaged to produce purines? What enzyme involved?
|
APRT(transferase) adds PRPP, forms AMP
|
|
how is hypoxanthine salvaged to produce purines? What enzyme involved?
|
HGPRT adds PRPP, forms AMP
|
|
how is guanine salvaged to produce purines? What enzyme involved?
|
HGPRT adds PRPP, forms AMP
|
|
fcn of HGPRT and APRT?
|
operate similar mechanism to recapture hypoxanthine, guanine, and adenine
|
|
what disease lacks HGPRT?
|
lesch-nyhan x-linked syndrome
|
|
significance of PRPP?
|
precursor for de novo synthesis, reactant for salvage
|
|
degradation of adenine nucleotides lead to
|
hypoxanthine→xanthine→uric acid via xanthine oxidase
|
|
degradation of guanine nucleotides lead to
|
xanthine→ uric acid via xanthine oxidase
|
|
pathway of GMP degradtion?
|
GMP→guanosine→(phosphorylase) guanine→xanthine→uric acid
|
|
pathway of AMP degradtion?
|
AMP→IMP→inosine→hypoxanthine→xanthine→uric acid
|
|
what is allopurinol?
|
drug used to treat hyperuricemia
|
|
fcn of allopurinol?
|
inhibits xanthine oxidase, controls production of uric acid. Increases IMP, GMP, decrease PRPP, resotres regulation of de novo purine synthesis
|
|
causes of hyperuricemia?
|
overactive de novo synthesis, lack of reutilization
|
|
what causes accelerated de novo purine sytnhesis?
|
increased intracellular nonpurine precursors, ex PRPP, ribose 5 P
|
|
cuase of decreased reutilization? Leads to?
|
lack of HGPRT. Leads to increased PRPP, dec salvaged purine nucleotides(IMP,AMP,GMP). Accelerates do novo synthesis, more uric acid
|
|
what does deficiency in purine nucleotide phosphorylase and adenosinedeaminase result in?
|
increased guanosine, adenosine leads to immunodefiecny disease. Toxic to B cells, T cells
|
|
what are the sources of C and N in pyrmidine nucleotide structure?
|
glutamine, aspartic acid, CO2
|
|
what part of the pyrimidine structure does glutamine provide?
|
N3
|
|
what part of the pyrimidine structure does CO2 provide?
|
C2
|
|
what part of the pyrimidine structure does aspartic acid provide?
|
C4,5,6, N1
|
|
what is the regulated step in formation of pyrimidine structures(OMP then UMP? Enzyme?
|
glutamine + CO2+ ATP→ carbomoyl phosphate via CPS II
|
|
what inhibits the regualted step in pyrimidine formation?
|
UTP, CTP
|
|
what goes into the formation of pyrimidine? What does it start with and end up with?
|
carbamoyl phospahte→NAD+, PRPP added, CO2 leaves→UDP→UTP→CTP
|
|
what enzyme is involved in formation of CTP? Reactant? Product?
|
UTP+ glutamine+ ATP→ CTP via CTP synthase
|
|
what activates CTP formation?
|
GTP
|
|
what are pyrimidine nucleotides degraded into?
|
CO2 + H20
|
|
what enzymes are targeted in cancer chemotherapy in nucleotide metabolism?
|
ribonucleotide reductase, thymidylate synthase, dihydrofolate reductase
|
|
fcn of ribonucleotide reductase?
|
reduces ribose to deoxyribose.
|
|
substrate of ribonucleotide reducatase? Significance?
|
thioredoxin. Uses NADPH from pentose phosphate pathway
|
|
what inactivates ribonucleotide reductase?
|
radical scavengers, ex. Hydroxyurea.
|
|
what acts as a master regulator of RR?
|
dATP
|
|
fcn of thymidylate synthase?
|
transfers 1 C from methylene FH4 to dUMP to form dTMP. Oxidizes tetrahydrofolate
|
|
what is 5 fluorouracil?
|
inactivates thymidylate synthase, blocks cell division
|
|
what is methotrexate?
|
inactivates dihydrofolate reductase, blocks re-reduction of hydrofolate
|
|
what is rescue therapy?
|
aggressive form of cancer therapy, blocks ALL cell division in body
|
|
what enzyme is used in rescue therapy?
|
N5 formyl tetrahydrofolate, reactivates enzymes
|